Inhibitors of the TRPC4 channel and CaMKII blocked the propagation of ZIKV in human brain organoids and improved the symptoms of epilepsy and survival in a neonatal mouse model of ZIKV infection. The gene discussed is CAMK2G; the disease is Zika virus infectious disease.